Due to this process, individuals suffering from stomach and small intestine disorders, such as Celiac disease, Chrohns disease and similar conditions, may be unable to absorb B12 from foods
What the SURMOUNT-5 Trial Means for UK Patients The publication of SURMOUNT-5 in the NEJM in 2025 was a landmark moment the first time tirzepatide and semaglutide were directly compared in a randomised controlled trial for weight management
Some people may experience mild complaints, for example from the digestive system, or allergic reactions
Presented for research literature review only Stancic-Rokotov D et al
adjunctive therapy in people with multiple seizure types that include absence seizures
CMAJ: Canadian Medical Association Journal, 196 (43), E1413